• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: December 2019

Pharma & Human Health

Carbiotix Signs Research Collaboration Agreement Focused on Neuroinflammation

December 23, 2019 Microbiome Times

Carbiotix (publ) (“Carbiotix”) announces today that the company has signed a collaboration agreement with the Department of Medicine at the University of Verona, Italy, to carry out a research study during H1 2020 in the […]

Editor's Choice

5-minute Microbiome Science Roundup: November 2019

December 18, 2019 Kristina Campbell

This month’s roundup begins with a paper describing what happens when bifidobacteria in the infant gut degrade human milk oligosaccharides; and another about the role of the infant airway microbiota in predicting later-life asthma. Next […]

Pharma & Human Health

Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test

December 17, 2019 Microbiome Times

Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., and CoreBiome, a wholly owned subsidiary of OraSure Technologies, Inc., announced today a collaboration to develop a new test called LifeKit® Prevent, which may represent a microbiome-driven […]

Pharma & Human Health

Princeton researchers listen in on the chemical conversation of the human microbiome

December 13, 2019 Microbiome Times

The microbial community populating the human body plays an important role in health and disease, but with few exceptions, how individual microbial species affect health and disease states remains poorly understood. A new study by […]

Finance

RB and Evolve BioSystems Team Up to Advance Infant Gut Health

December 10, 2019 Microbiome Times

RB and Evolve BioSystems announce a partnership in the sale of Evivo®, Evolve BioSystems’ infant probiotic. The partnership leverages assets and expertise from both companies to drive scale in messaging directly to consumers and health […]

Pharma & Human Health

Investigating the human intestinal mucus barrier up-close and personal

December 9, 2019 Benjamin Boettner

We have a mutualistic but complicated relationship with the collection of microbes in our gut known as the intestinal microbiome. This complex community of bacteria breaks down different food components, and releases nutrients such as […]

Pharma & Human Health

Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study

December 4, 2019 Microbiome Times

Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to protect the intestinal microbiota, announced the results of DAV132- CL-1005, a Phase 1 clinical study which investigated the potential effect of DAV132 on the bioavailability […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
sign up

Sign up to the Microbiome Times newsletter